Z
ZLAB
Zai Lab Limited
20.04
-0.04-0.20%After Hours: 20.01 -0.03 -0.15%19:57 02/20 EST
OPEN/PREV CLOSE19.87/20.08
TODAY RANGE19.60-20.21
VOL521.03K
MARKET CAP2.22B
52 WEEK RANGE15.96-44.34
AVG VOL (3M)822.55K
% TURNOVER0.47%
TURNOVER--
P/E (TTM)-10.3150
% RANGE3.01%
EPS(TTM)-1.9428
P/E(FORWARD)-12.6835
P/B2.916
BVPS6.87
DIVIDEND--
P/S5.41
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.14B
SHARES OUTSTANDING110.59M
NEXT EARNINGS02/25-03/02
FREE FLOAT106.96M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·23h ago
Zai Lab price target lowered to $53 from $58 at Citi
TipRanks·02/13 16:30
Zai Lab Advances New Solid Tumor Drug ZL-1310: What Investors Should Watch
Reuters·02/10 13:30
Zai Lab Ltd. hat eine Aktualisierung ihres Finanzkalenders veröffentlicht
Reuters·02/10 13:30
Zai Lab Ltd. to Announce Fourth Quarter and Full Year Financial Results
TipRanks·02/09 16:36
Bernstein Keeps Their Hold Rating on Zai Lab Ltd (1ZLB)
Dow Jones·02/05 18:52
Zai Lab Is Maintained at Overweight by JP Morgan
Dow Jones·02/05 18:52
Zai Lab Price Target Cut to $39.00/Share From $46.00 by JP Morgan
Benzinga·02/05 18:43
JP Morgan Maintains Overweight on Zai Lab, Lowers Price Target to $39
Seeking Alpha·02/05 15:03
NovoCure projects $13M monthly revenue hit as Medicare revokes billing privileges
TipRanks·02/05 13:36
Zai Lab price target lowered to $39 from $46 at JPMorgan
Seeking Alpha·02/04 18:32
ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025
Benzinga·02/03 11:23
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter
TipRanks·02/03 05:06
SPDB Reaffirms Their Buy Rating on Zai Lab Ltd (1ZLB)
Same Industry
Name/Symbol
Change%
Price